Literature DB >> 12383966

Central alpha-melanocyte-stimulating hormone acts at melanocortin-4 receptor to activate sympathetic nervous system in conscious rabbits.

Kiyoshi Matsumura1, Takuya Tsuchihashi, Isao Abe, Mitsuo Iida.   

Abstract

Intracerebroventricular injection of alpha-melanocyte-stimulating hormone (alpha-MSH) elicited increases in arterial pressure and renal sympathetic nerve activity in conscious rabbits. Pretreatment with intracerebroventricular injection of agouti-related protein, an endogenous melanocortin-3 and 4 receptor antagonist, prevented cardiovascular and sympathetic responses to alpha-MSH. Pretreatment with intracerebroventricular injection of JKC-363, a synthetic specific melanocortin-4 receptor antagonist, also prevented cardiovascular and sympathetic responses to alpha-MSH. In contrast, intravenous alpha-MSH (1 nmol) failed to cause any cardiovascular responses. These results suggest that intracerebroventricularly administered alpha-MSH acts at the melanocortin-4 receptor in the brain and activates sympathetic outflow, resulting in an increase in arterial pressure. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12383966     DOI: 10.1016/s0006-8993(02)03045-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  19 in total

Review 1.  Central nervous system dysfunction in obesity-induced hypertension.

Authors:  Geoffrey A Head; Kyungjoon Lim; Benjamin Barzel; Sandra L Burke; Pamela J Davern
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

Review 2.  Role of the brain melanocortins in blood pressure regulation.

Authors:  Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Taolin Fang; Nicola Aberdein; Cecilia E Perez de Lara; John E Hall
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-06       Impact factor: 5.187

3.  Simultaneous POMC gene transfer to hypothalamus and brainstem increases physical activity, lipolysis and reduces adult-onset obesity.

Authors:  Yi Zhang; Enda Rodrigues; Gang Li; Yongxin Gao; Michael King; Christy S Carter; Nihal Tumer; Kit-Yan Cheng; Philip J Scarpace
Journal:  Eur J Neurosci       Date:  2011-03-02       Impact factor: 3.386

Review 4.  Cardiovascular effects of melanocortins.

Authors:  Michael H Humphreys; Xi-Ping Ni; David Pearce
Journal:  Eur J Pharmacol       Date:  2011-01-01       Impact factor: 4.432

5.  The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

Authors:  Ya-Xiong Tao
Journal:  Endocr Rev       Date:  2010-02-26       Impact factor: 19.871

6.  The alternative stimulatory G protein alpha-subunit XLalphas is a critical regulator of energy and glucose metabolism and sympathetic nerve activity in adult mice.

Authors:  Tao Xie; Antonius Plagge; Oksana Gavrilova; Stephanie Pack; William Jou; Edwin W Lai; Marga Frontera; Gavin Kelsey; Lee S Weinstein
Journal:  J Biol Chem       Date:  2006-05-02       Impact factor: 5.157

7.  Microinjections of alpha-melanocyte stimulating hormone into the nucleus ambiguus of the rat elicit vagally mediated bradycardia.

Authors:  Vineet C Chitravanshi; Suresh Bhatt; Hreday N Sapru
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-03-18       Impact factor: 3.619

8.  AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality.

Authors:  K Doi; X Hu; P S T Yuen; A Leelahavanichkul; H Yasuda; S M Kim; J Schnermann; T E N Jonassen; J Frøkiaer; S Nielsen; R A Star
Journal:  Kidney Int       Date:  2008-03-19       Impact factor: 10.612

9.  Bombesin-like receptor 3 regulates blood pressure and heart rate via a central sympathetic mechanism.

Authors:  Dalya M Lateef; Cuiying Xiao; Robert J Brychta; André Diedrich; Jurgen Schnermann; Marc L Reitman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-22       Impact factor: 4.733

10.  Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system.

Authors:  Gina L C Yosten; Willis K Samson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-05-27       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.